Kolexia
Zucman-Rossi Jessica
Médecine interne
Hôpital Européen Georges Pompidou
Paris, France
394 Activités
1.4 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du foie Carcinomes Carcinome hépatocellulaire Néphrocarcinome Adénome hépatocellulaire Adénomes Tumeurs du rein Carcinogenèse Transformation cellulaire néoplasique

Industries

Health Advances
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Author Correction: Hepatocellular carcinoma.
Nature reviews. Disease primers   12 février 2024
DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
Molecular therapy : the journal of the American Society of Gene Therapy   03 février 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
European journal of cancer (Oxford, England : 1990)   01 février 2024
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma.
Nature communications   06 novembre 2023
A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Hepatology (Baltimore, Md.)   23 octobre 2023
1907P Multi-omics mapping positions antigenic myeloid-T cell crosstalk at the core of advanced renal cell carcinoma (aRCC) response to immune checkpoint blockade (ICB)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Dynamic evolution of circulating tumor DNA in patients with hepatocellular carcinoma across tumor stages and treatments
Abstracts of the A.I.S.F. - Italian Association for the Study of the Liver Monothematic Conference “Liver oncology: from basic science to liver transplantation" Padua, September 28th-29th, 2023   01 septembre 2023
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Journal of hepatology   28 août 2023
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
Journal of hepatology   10 juin 2023
RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis.
Journal of hepatology   16 mai 2023